Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy.

Bourgi K, Rebeiro PF, Turner M, Castilho JL, Hulgan T, Raffanti SP, Koethe JR, Sterling TR.

Clin Infect Dis. 2019 May 17. pii: ciz407. doi: 10.1093/cid/ciz407. [Epub ahead of print]

PMID:
31100116
2.

Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV.

Lee JT, Saag LA, Kipp AM, Logan J, Shepherd BE, Koethe JR, Turner M, Bebawy S, Sterling TR, Hulgan T.

AIDS Behav. 2019 Feb 18. doi: 10.1007/s10461-019-02430-x. [Epub ahead of print]

PMID:
30778810
3.

Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality.

Zhang X, Hu Y, Aouizerat BE, Peng G, Marconi VC, Corley MJ, Hulgan T, Bryant KJ, Zhao H, Krystal JH, Justice AC, Xu K.

Clin Epigenetics. 2018 Dec 13;10(1):155. doi: 10.1186/s13148-018-0591-z.

4.

Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.

Hulgan T, Kallianpur AR, Guo Y, Barnholtz-Sloan JS, Gittleman H, Brown TT, Ellis R, Letendre S, Heaton RK, Samuels DC; CHARTER Study.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):e95-e102. doi: 10.1097/QAI.0000000000001930.

PMID:
30531306
5.

Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy.

Hulgan T, Ramsey BS, Koethe JR, Samuels DC, Gerschenson M, Libutti DE, Sax PE, Daar ES, McComsey GA, Brown TT.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):358-366. doi: 10.1097/QAI.0000000000001926.

PMID:
30531304
6.

Precision HIV care: responding to old questions and meeting new challenges.

Hulgan T, Dash C, Haas DW, Phillips EJ.

Pharmacogenomics. 2018 Nov;19(17):1299-1302. doi: 10.2217/pgs-2018-0126. Epub 2018 Oct 16. No abstract available.

7.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2019 May;56(5):3808-3818. doi: 10.1007/s12035-018-1329-9. Epub 2018 Sep 12.

PMID:
30209774
8.

Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

Smieszek S, Jia P, Samuels DC, Zhao Z, Barnholtz-Sloan J, Kaur H, Letendre S, Ellis R, Franklin DR, Hulgan T, Kallianpur A, Bush WS; CHARTER Study Group.

Mitochondrion. 2019 May;46:247-255. doi: 10.1016/j.mito.2018.07.004. Epub 2018 Jul 17.

9.

Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.

Kallianpur AR, Gerschenson M, Hulgan T, Kaur H, Clifford DB, Haas DW, Murdock DG, McArthur JC, Samuels DC, Simpson DM.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):942-949. doi: 10.1089/AID.2018.0025. Epub 2018 Aug 22.

PMID:
29968489
10.

Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy.

Koethe JR, Jenkins CA, Furch BD, Lake JE, Barnett L, Hager CC, Smith R, Hulgan T, Shepherd BE, Kalams SA.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):135-140. doi: 10.1097/QAI.0000000000001768.

PMID:
29794823
11.

Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Hulgan T.

Curr HIV/AIDS Rep. 2018 Jun;15(3):223-232. doi: 10.1007/s11904-018-0399-7. Review.

12.

Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.

Bailin SS, Jenkins CA, Petucci C, Culver JA, Shepherd BE, Fessel JP, Hulgan T, Koethe JR.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):536-543. doi: 10.1089/AID.2017.0314. Epub 2018 May 2.

13.

The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living With Human Immunodeficiency Virus.

Sun J, Brown TT, Samuels DC, Hulgan T, D'Souza G, Jamieson BD, Erlandson KM, Martinson J, Palella FJ Jr, Margolick JB, Kirk GD, Schrack JA.

Clin Infect Dis. 2018 Aug 16;67(5):778-784. doi: 10.1093/cid/ciy151.

PMID:
29481608
14.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

15.

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.

Norwood J, Turner M, Bofill C, Rebeiro P, Shepherd B, Bebawy S, Hulgan T, Raffanti S, Haas DW, Sterling TR, Koethe JR.

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):527-531. doi: 10.1097/QAI.0000000000001525.

16.

An Innovative Approach to Addressing the HIV Care Continuum: Implementation of a Clinical Pharmacy Resident in a Veterans Affairs HIV Specialty Clinic.

Bagwell A, McFarland MS, Hulgan T.

J Pharm Pract. 2018 Oct;31(5):422-428. doi: 10.1177/0897190017715580. Epub 2017 Jun 22.

PMID:
28639465
17.

New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States.

Rebeiro PF, Ivey KS, Craig KS, Hulgan T, Huaman MA, Nash R, Raffanti S, Equakun KA, Person AK.

J Int Assoc Provid AIDS Care. 2017 Jul/Aug;16(4):347-352. doi: 10.1177/2325957417710719. Epub 2017 May 31.

18.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

19.

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.

Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, Franklin DR, Kaur H, Iudicello J, Grant I, Kallianpur AR.

Fluids Barriers CNS. 2017 Apr 21;14(1):11. doi: 10.1186/s12987-017-0058-1.

20.

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.

Mehta SR, Pérez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben JD, Franklin D, Rosario D, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A.

J Neuroinflammation. 2017 Mar 31;14(1):72. doi: 10.1186/s12974-017-0848-z.

21.

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.

Samuels DC, Kallianpur AR, Ellis RJ, Bush WS, Letendre S, Franklin D, Grant I, Hulgan T.

Pathog Immun. 2016 Fall-Winter;1(2):330-351. doi: 10.20411/pai.v1i2.156.

22.

Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care.

Kipp AM, Rebeiro PF, Shepherd BE, Brinkley-Rubinstein L, Turner M, Bebawy S, Sterling TR, Hulgan T.

AIDS Behav. 2017 Jul;21(7):1996-2004. doi: 10.1007/s10461-017-1716-7.

23.

Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.

Le CN, Hulgan T, Tseng CH, Milne GL, Lake JE.

PLoS One. 2017 Jan 24;12(1):e0170515. doi: 10.1371/journal.pone.0170515. eCollection 2017.

24.

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

Levinson RT, Hulgan T, Kalams SA, Fessel JP, Samuels DC.

Open Forum Infect Dis. 2016 Oct 19;3(4):ofw184. eCollection 2016 Oct.

25.

Subjective memory complaints are associated with poorer cognitive performance in adults with HIV.

Kamkwalala A, Hulgan T, Newhouse P.

AIDS Care. 2017 May;29(5):654-659. doi: 10.1080/09540121.2016.1248348. Epub 2016 Oct 28.

26.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

27.

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.

Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS.

Open Forum Infect Dis. 2015 Apr 26;2(2):ofv059. doi: 10.1093/ofid/ofv059. eCollection 2015 Apr.

28.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR; CHARTER Group.

Clin Infect Dis. 2015 Nov 1;61(9):1476-84. doi: 10.1093/cid/civ527. Epub 2015 Jun 30.

29.

Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns.

Chastain CA, Beekmann SE, Wallender EK, Hulgan T, Stapleton JT, Polgreen PM.

Clin Infect Dis. 2015 Sep 1;61(5):792-4. doi: 10.1093/cid/civ384. Epub 2015 May 15.

PMID:
25979310
30.

Pharmacogenomics of antimicrobial agents.

Aung AK, Haas DW, Hulgan T, Phillips EJ.

Pharmacogenomics. 2014;15(15):1903-30. doi: 10.2217/pgs.14.147. Review.

31.

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report.

Qian HZ, Mitchell VJ, Bebawy S, Cassell H, Perez G, McGowan CC, Sterling TR, Vermund SH, D'Aquila R, Hulgan T.

BMC Infect Dis. 2014 Sep 18;14:508. doi: 10.1186/1471-2334-14-508.

32.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I; CHARTER Study Group.

PLoS One. 2014 Aug 21;9(8):e103123. doi: 10.1371/journal.pone.0103123. eCollection 2014.

33.

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.

Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE.

Mediators Inflamm. 2014;2014:803095. doi: 10.1155/2014/803095. Epub 2014 Jun 1.

34.

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy.

Hulgan T, Levinson RT, Gerschenson M, Phanuphak N, Ananworanich J, Teeratakulpisarm N, Jadwattanakul T, LiButti DE, Fink H, McArthur JC, Ebenezer GJ, Hauer P, Murdock D, Shikuma CM, Samuels DC; SEARCH 003 Study Team.

AIDS. 2014 Jul 17;28(11):1625-33. doi: 10.1097/QAD.0000000000000297.

35.

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.

Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Stramotas SA, Tracy R, Currier JS.

HIV Med. 2014 Aug;15(7):431-41. doi: 10.1111/hiv.12128. Epub 2014 Feb 10.

37.

Higher serum iron is associated with increased oxidant stress in HIV-infected men.

Crist MB, Melekhin VV, Bian A, Shintani A, Milne GL, Kallianpur AR, Dageforde LA, Haas DW, Hulgan T.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):367-73. doi: 10.1097/QAI.0b013e3182a60f36.

38.

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.

Hulgan T, Stein JH, Cotter BR, Murdock DG, Ritchie MD, Dube MP, Gerschenson M, Haas DW, Torriani FJ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1293-9. doi: 10.1089/aid.2013.0079. Epub 2013 Aug 14.

39.

Adipose tissue and immune function: a review of evidence relevant to HIV infection.

Koethe JR, Hulgan T, Niswender K.

J Infect Dis. 2013 Oct 15;208(8):1194-201. doi: 10.1093/infdis/jit324. Epub 2013 Jul 21. Review.

41.

An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study.

Koethe JR, Bian A, Shintani AK, Wester CW, Erdem H, Hulgan T.

Antivir Ther. 2013;18(5):729-33. doi: 10.3851/IMP2645. Epub 2013 Jun 7.

42.

Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.

Koethe JR, Dee K, Bian A, Shintani A, Turner M, Bebawy S, Sterling TR, Hulgan T.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1019-25. doi: 10.1089/AID.2013.0016. Epub 2013 Apr 11.

43.

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study.

Sinxadi PZ, Dave JA, Samuels DC, Heckmann JM, Maartens G, Levitt NS, Wester CW, Haas DW, Hulgan T.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1031-9. doi: 10.1089/AID.2012.0373. Epub 2013 Mar 15.

44.

Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons.

Alves TP, Wu P, Ikizler TA, Sterling TR, Stinnette SE, Rebeiro PF, Ghosh S, Hulgan T.

Clin Nephrol. 2013 Feb;79(2):93-100. doi: 10.5414/CN107390.

45.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I; CHARTER Group.

J Neurovirol. 2012 Dec;18(6):511-20. doi: 10.1007/s13365-012-0133-y. Epub 2012 Oct 17.

46.

T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.

Hulgan T, Robbins GK, Kalams SA, Samuels DC, Grady B, Shafer R, Murdock DG, Selph D, Haas DW, Pollard RB; AIDS Clinical Trials Group.

PLoS One. 2012;7(8):e43803. doi: 10.1371/journal.pone.0043803. Epub 2012 Aug 27.

47.

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS.

AIDS Patient Care STDS. 2012 Sep;26(9):532-40. doi: 10.1089/apc.2012.0135. Epub 2012 Jul 23.

48.

Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits.

Rasbach DA, Desruisseau AJ, Kipp AM, Stinnette S, Kheshti A, Shepherd BE, Sterling TR, Hulgan T, McGowan CC, Qian HZ.

AIDS Care. 2013;25(1):109-17. doi: 10.1080/09540121.2012.687814. Epub 2012 Jun 6.

49.

Measures of small-fiber neuropathy in HIV infection.

Boger MS, Hulgan T, Haas DW, Mitchell V, Smith AG, Singleton JR, Peltier AC.

Auton Neurosci. 2012 Jul 2;169(1):56-61. doi: 10.1016/j.autneu.2012.04.001. Epub 2012 Apr 28.

50.

HIV and mitochondria: more than just drug toxicity.

Hulgan T, Gerschenson M.

J Infect Dis. 2012 Jun 15;205(12):1769-71. doi: 10.1093/infdis/jis105. Epub 2012 Apr 3. No abstract available.

Supplemental Content

Loading ...
Support Center